BioVoice News November 2017 Issue 6 Volume 2 | Page 14

UnimAginABLe LOng TeRm cOnseqUences classification for antibiotics to preserve the effectiveness of those that are a ‘last resort’. The new model comprised three categories: ‘Key Access’ antibiotics that should be widely available, ‘Watch Group’ that includes critically important antimicrobials which should only be used for certain infections, and ‘Reserve Group’ antibiotics for severe circumstances when all alternatives have failed. The WHO in June 2017, adopted a new As per Dr Sumanth Gandra who was on the and the Dominican Republic. A quarter of the 169 vegetable samples imported into Switzerland from the four countries revealed one or more extended-spectrum beta- lactamase (ESBL) producing bacteria called Enterobacteriaceae. Over 78 percent of the bacteria were found to be multi- drug resistant. WHO’s expert committee, “The categorization was done not only to improve access, but at the same time to reduce the potential for development of antibiotic resistance, and preserve the effectiveness of ‘last resort’ antibiotics.” “In India, resistance to last resort drug “colistin” is increasing in a bacterium called K. pneumonia which causes serious infections among hospitalized patients. Unfortunately, we do not have any antibiotics to treat colistin resistant K. pneumonia infections,” says Dr Gandra, who is also a Resident Scholar and Fellow, Center for Disease Dynamics, Economics & Policy (CDDEP). Antimicrobial growth promotion (AGP) use in farm animals is increasing worldwide in response to the rising demand for food animal products. Previous 14 BioVoiceNews | November 2017